Cosciens Biopharma Inc (CSCIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,524 | 9,333 | 13,758 | 16,393 | 19,998 |
| Receivables | 1,605 | 2,783 | 1,859 | 2,471 | 2,015 |
| Inventories | 1,759 | 1,821 | 2,455 | 2,691 | 3,306 |
| Other current assets | 286 | 0 | 0 | 0 | 0 |
| TOTAL | $13,835 | $16,503 | $20,354 | $23,981 | $28,221 |
| Non-Current Assets | |||||
| PPE Net | 9,892 | 10,923 | 10,659 | 10,966 | 11,807 |
| Investments And Advances | 0 | 0 | 0 | 0 | 729 |
| Intangibles | 0 | 0 | 0 | 0 | 1,807 |
| Other Non-Current Assets | 132 | 132 | 128 | 123 | 1,205 |
| TOTAL | $10,024 | $11,055 | $10,787 | $11,089 | $15,548 |
| Total Assets | $23,859 | $27,558 | $31,141 | $35,070 | $43,769 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,948 | 3,056 | 4,711 | 4,730 | 4,817 |
| Other current liabilities | 1,686 | 2,130 | 1,864 | 1,987 | 2,786 |
| TOTAL | $3,983 | $5,532 | $7,059 | $7,213 | $8,167 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 19 | 19 | 122 | 120 | 46 |
| Other Non-Current Liabilities | 13,766 | 13,901 | 13,008 | 13,782 | 13,664 |
| TOTAL | $14,796 | $14,929 | $13,938 | $14,696 | $15,588 |
| Total Liabilities | $18,779 | $20,461 | $20,997 | $21,909 | $23,755 |
| Shareholders' Equity | |||||
| Common Shares | 22,622 | 22,600 | 22,503 | 22,486 | 22,388 |
| Retained earnings | -19,048 | -17,227 | -14,655 | -12,110 | -5,158 |
| Other shareholders' equity | -2,662 | -2,466 | -1,979 | -1,483 | -1,553 |
| TOTAL | $5,080 | $7,097 | $10,144 | $13,161 | $20,014 |
| Total Liabilities And Equity | $23,859 | $27,558 | $31,141 | $35,070 | $43,769 |